If imitation is the sincerest form of flattery, we’ll humbly accept the compliment. Since 2022, TelyRx has been pioneering the direct-to-patient prescription model, and it’s exciting to see the industry catching up.
Recent announcements from the White House concerning the TrumpRx website, and the pharmaceutical industry’s introduction of AmericasMedicines.com, mark a pivotal moment for healthcare. Both initiatives aim to make prescription medications more accessible to Americans through direct-to-consumer channels—a mission that aligns perfectly with what we’ve been building at TelyRx.
For us, these developments are more than just validation; they’re tailwinds for our model’s goal of increasing patient access to medicines via the internet. When both the federal government and the pharmaceutical industry embrace direct-to-patient medication access using platforms like TelyRx.com, it’s a clear signal that our model isn’t just viable—it’s the future. Americans deserve straightforward, convenient access to the medications they rely on, and that future is long overdue.